NSE
Advanced Enzyme Technologies LimitedADVENZYMES
Advanced Enzyme Technologies Limited is an Indian company engaged in the manufacturing and supply of enzymes for various applications.
| Key products | Enzymes for food, pharmaceuticals, and industrial uses |
|---|---|
| Geography | India (domestic market) |
| Competitors | Low confidence; specific competitors not readily available |
AI-generated overview — verify before relying on it.
Net institutional flow
+₹44.2 Cr
Institutional buyers
1 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Dividend - Rs 1.20 Per Share
ex 2025-07-23
Competitive landscape — the read
vs most-traded names| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ADVENZYMESThis | +₹44.2 Cr | 5 | — | — | — | — |
| 2 | MTNL | +₹41.3 Cr | 331 | — | — | — | — |
| 3 | ATALREAL | +₹7.4 Cr | 363 | — | — | — | — |
| 4 | GATECH | +₹0.4 Cr | 298 | — | — | — | — |
| 5 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 6 | QUADFUTURE | −₹9 Cr | 571 | — | — | — | — |
| 7 | MOBIKWIK | −₹150.9 Cr | 975 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Weaknesses
- • [object Object]
- • [object Object]
Threats
- • [object Object]
- • [object Object]
AI-generated from our data — verify before relying on it.
Timeline — ADVENZYMES day by day
- 2026-06-12FilingAdvanced Enzyme Technologies Limited has informed the Exchange about Copy of Newspaper PublicationCompliance
- 2026-06-12FilingChandrakumar Laxminarayan Rathi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of tShareholding Disclosure
- 2026-06-11FilingAdvanced Enzyme Technologies Limited has informed the Exchange regarding Change in Director(s) of the company.Management
- 2025-08-29BulkBUY · ₹35.5 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-08-29BulkSELL · ₹35.5 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-08-29BulkBUY · ₹44.2 CrPOLUNIN EMERGING MARKETS SMALL CAP FUND LLC
- 2025-07-23ActionDividend - Rs 1.20 Per ShareDividend
- 2025-05-16ActionInterim Dividend - Rs 4 Per ShareDividend
- 2024-09-11BulkSELL · ₹41.7 CrGRAVITON RESEARCH CAPITAL LLP
- 2024-09-11BulkBUY · ₹41.7 CrGRAVITON RESEARCH CAPITAL LLP
- 2024-07-18ActionDividend - Re 1.1 Per ShareDividend
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
- 1
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF → - 2
5 deals · 2024-09-11 → 2025-08-29
| Date | Counterparty | Investor type | Side | Value |
|---|---|---|---|---|
| 2025-08-29 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | BUY | ₹35.5 Cr |
| 2025-08-29 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | SELL | ₹35.5 Cr |
| 2025-08-29 | POLUNIN EMERGING MARKETS SMALL CAP FUND LLC | Institution | BUY | ₹44.2 Cr |
| 2024-09-11 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | SELL | ₹41.7 Cr |
| 2024-09-11 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | BUY | ₹41.7 Cr |
5 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on ADVENZYMES
RSS News
0No recent news.
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.